Millennium Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $80M | Buy |
574,100
+131,600
| +30% | +$18.4M | 0.03% | 556 |
|
|
2025
Q4 | $54.3M | Buy |
442,500
+34,400
| +8% | +$4.18M | 0.02% | 763 |
|
|
2025
Q3 | $45.3M | Sell |
408,100
-221,500
| -35% | -$25.2M | 0.02% | 944 |
|
|
2025
Q2 | $69.8M | Sell |
629,600
-220,300
| -26% | -$23.4M | 0.03% | 611 |
|
|
2025
Q1 | $95.2M | Buy |
849,900
+388,200
| +84% | +$40.1M | 0.05% | 373 |
|
|
2024
Q4 | $42.6M | Sell |
461,700
-494,100
| -52% | -$44.5M | 0.02% | 890 |
|
|
2024
Q3 | $80.1M | Buy |
955,800
+595,300
| +165% | +$45.4M | 0.04% | 551 |
|
|
2024
Q2 | $24.7M | Sell |
360,500
-204,800
| -36% | -$13.7M | 0.01% | 1313 |
|
|
2024
Q1 | $41.4M | Sell |
565,300
-243,300
| -30% | -$18.7M | 0.02% | 956 |
|
|
2023
Q4 | $65.5M | Buy |
808,600
+331,700
| +70% | +$25.8M | 0.03% | 635 |
|
|
2023
Q3 | $35.7M | Sell |
476,900
-8,800
| -2% | -$677K | 0.02% | 942 |
|
|
2023
Q2 | $37.4M | Sell |
485,700
-83,100
| -15% | -$6.63M | 0.02% | 931 |
|
|
2023
Q1 | $47.2M | Sell |
568,800
-1,833,100
| -76% | -$152M | 0.03% | 722 |
|
|
2022
Q4 | $206M | Buy |
2,401,900
+651,200
| +37% | +$51.6M | 0.11% | 135 |
|
|
2022
Q3 | $108M | Buy |
1,750,700
+63,000
| +4% | +$3.97M | 0.06% | 290 |
|
|
2022
Q2 | $104M | Sell |
1,687,700
-63,500
| -4% | -$3.93M | 0.06% | 288 |
|
|
2022
Q1 | $104M | Sell |
1,751,200
-396,200
| -18% | -$25.3M | 0.06% | 323 |
|
|
2021
Q4 | $156M | Buy |
2,147,400
+912,800
| +74% | +$62.9M | 0.08% | 203 |
|
|
2021
Q3 | $86.2M | Buy |
1,234,600
+213,000
| +21% | +$15M | 0.05% | 372 |
|
|
2021
Q2 | $70.3M | Buy |
1,021,600
+210,800
| +26% | +$14.1M | 0.04% | 448 |
|
|
2021
Q1 | $52.4M | Sell |
810,800
-50,800
| -6% | -$3.28M | 0.04% | 467 |
|
|
2020
Q4 | $50.2M | Buy |
861,600
+223,200
| +35% | +$13.5M | 0.04% | 456 |
|
|
2020
Q3 | $40.3K | Sell |
638,400
-181,200
| -22% | -$12.6M | 0.05% | 414 |
|
|
2020
Q2 | $63.1M | Sell |
819,600
-36,800
| -4% | -$2.82M | 0.09% | 210 |
|
|
2020
Q1 | $64M | Buy |
856,400
+105,300
| +14% | +$7.28M | 0.14% | 118 |
|
|
2019
Q4 | $48.8M | Buy |
751,100
+350,500
| +87% | +$22.8M | 0.06% | 378 |
|
|
2019
Q3 | $25.4M | Buy |
400,600
+266,700
| +199% | +$17.4M | 0.04% | 631 |
|
|
2019
Q2 | $9.05M | Buy |
+133,900
| New | +$8.81M | 0.01% | 1334 |
|
|
2015
Q3 | – | Sell |
-300,000
| Closed | -$35.1M | – | 3552 |
|
|
2015
Q2 | $35.1M | Buy |
+300,000
| New | +$32.8M | 0.07% | 381 |
|
|
2015
Q1 | – | Sell |
-13,000
| Closed | -$1.23M | – | 3766 |
|
|
2014
Q4 | $1.23M | Buy |
13,000
+11,000
| +550% | +$1.14M | ﹤0.01% | 2349 |
|
|
2014
Q3 | $213K | Sell |
2,000
-328,000
| -99% | -$32.1M | ﹤0.01% | 3375 |
|
|
2014
Q2 | $27.4M | Buy |
330,000
+21,900
| +7% | +$1.7M | 0.08% | 344 |
|
|
2014
Q1 | $21.8M | Buy |
308,100
+193,100
| +168% | +$15.1M | 0.06% | 411 |
|
|
2013
Q4 | $8.64M | Buy |
+115,000
| New | +$8.01M | 0.03% | 809 |
|
|
2013
Q3 | – | Sell |
-156,500
| Closed | -$8.02M | – | 3406 |
|
|
2013
Q2 | $8.02M | Buy |
+156,500
| New | +$8.16M | 0.02% | 742 |
|
Other funds holding GILD
VCM
VPM
Millennium Management's GILD Position: Q1 2026 in Review
Millennium Management increased its Gilead Sciences (GILD) stake by 769% in Q1 2026, buying an estimated $146M and bringing the position to 1,180,760 shares worth $165M. The position accounts for 0.07% of the portfolio, ranked #261.
Millennium Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $284M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Millennium Management held 1,180,760 shares of Gilead Sciences worth $165M as of Q1 2026.
- Millennium Management bought 1,044,841 Gilead Sciences shares in Q1 2026, an estimated $146M.
- Gilead Sciences made up 0.07% of Millennium Management's portfolio in Q1 2026, its #261 holding.
- Millennium Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Millennium Management's Gilead Sciences position peaked at $284M in Q1 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.